TENAX THERAPEUTICS, INC. Proceeds from Issuance or Sale of Equity
TENAX THERAPEUTICS, INC. (TENX) reported Proceeds from Issuance or Sale of Equity of $9.19 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-29.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOrSaleOfEquity · last filed 2022-03-29
- TENAX THERAPEUTICS, INC. proceeds from issuance or sale of equity for the quarter ending 2021-12-31 was $0.00.
- TENAX THERAPEUTICS, INC. proceeds from issuance or sale of equity for the quarter ending 2021-09-30 was $9.19M, a 40.71% increase year-over-year.
- TENAX THERAPEUTICS, INC. proceeds from issuance or sale of equity for the quarter ending 2021-06-30 was $0.00.
- TENAX THERAPEUTICS, INC. proceeds from issuance or sale of equity for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
- TENAX THERAPEUTICS, INC. proceeds from issuance or sale of equity for fiscal 2021 was $9.19M, a 6.16% increase from fiscal 2020.
- TENAX THERAPEUTICS, INC. proceeds from issuance or sale of equity for fiscal 2020 was $8.66M.
- TENAX THERAPEUTICS, INC. proceeds from issuance or sale of equity for fiscal 2016 was $0.00.
- TENAX THERAPEUTICS, INC. proceeds from issuance or sale of equity for fiscal 2015 was $544.00K, a 99.12% decline from fiscal 2014.
| Period end | Proceeds from Issuance or Sale of Equity 3 month | Proceeds from Issuance or Sale of Equity 3 month as first filed | Proceeds from Issuance or Sale of Equity 6 month | Proceeds from Issuance or Sale of Equity 6 month as first filed | Proceeds from Issuance or Sale of Equity 8 month | Proceeds from Issuance or Sale of Equity 9 month | Proceeds from Issuance or Sale of Equity 12 month | Proceeds from Issuance or Sale of Equity 530 month | Proceeds from Issuance or Sale of Equity 533 month | Proceeds from Issuance or Sale of Equity 536 month | Proceeds from Issuance or Sale of Equity 539 month | Proceeds from Issuance or Sale of Equity 542 month | Proceeds from Issuance or Sale of Equity 545 month | Proceeds from Issuance or Sale of Equity 554 month | Proceeds from Issuance or Sale of Equity 557 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $9.19M derived: sum of 2 quarters · filed 2022-03-29 | $9.19M derived: sum of 3 quarters · filed 2022-03-29 | $9.19M 10-K · filed 2022-03-29 | |||||||||||
| 2021-09-30 | $9.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $9.19M derived: sum of 2 quarters · filed 2021-11-15 | $9.19M 10-Q · filed 2021-11-15 | $9.19M derived: sum of 4 quarters · filed 2022-03-29 | |||||||||||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $0.00 10-Q · filed 2021-08-16 | -$3.81K derived: sum of 3 quarters · filed 2022-03-29 | $6.53M derived: sum of 4 quarters · filed 2022-03-29 | |||||||||||
| 2021-03-31 | $0.00 10-Q · filed 2021-05-17 | -$3.81K derived: sum of 2 quarters · filed 2022-03-29 | $6.53M derived: sum of 3 quarters · filed 2022-03-29 | $6.53M derived: sum of 4 quarters · filed 2022-03-29 | |||||||||||
| 2020-12-31 | -$3.81K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $6.53M derived: sum of 2 quarters · filed 2022-03-29 | $6.53M derived: sum of 3 quarters · filed 2022-03-29 | $8.66M 10-K · filed 2022-03-29 | |||||||||||
| 2020-09-30 | $6.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $6.53M derived: sum of 2 quarters · filed 2021-11-15 | $8.66M 10-Q · filed 2021-11-15 | ||||||||||||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $2.13M 10-Q · filed 2021-08-16 | |||||||||||||
| 2020-03-31 | $2.13M 10-Q · filed 2021-05-17 | ||||||||||||||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $0.00 derived: sum of 2 quarters · filed 2020-11-16 | $0.00 10-Q · filed 2020-11-16 | ||||||||||||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $0.00 10-Q · filed 2020-08-14 | |||||||||||||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-15 | $96.50K 10-Q · filed 2019-05-15 | |||||||||||||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-15 | ||||||||||||||
| 2016-12-31 | $0.00 10-K · filed 2017-03-16 | ||||||||||||||
| 2015-12-31 | $0.00 10-K · filed 2017-03-16 | ||||||||||||||
| 2015-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-12-10 | $0.00 10-Q · filed 2015-12-10 | $0.00 derived: sum of 3 quarters · filed 2017-03-16 | $0.00 derived: sum of 4 quarters · filed 2017-03-16 | |||||||||||
| 2015-07-31 | $0.00 10-Q · filed 2015-09-09 | $0.00 derived: sum of 2 quarters · filed 2017-03-16 | $0.00 derived: sum of 3 quarters · filed 2017-03-16 | $0.00 derived: sum of 4 quarters · filed 2017-03-16 | |||||||||||
| 2015-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $0.00 derived: sum of 2 quarters · filed 2017-03-16 | $0.00 derived: sum of 3 quarters · filed 2017-03-16 | $544.00K 10-K · filed 2017-03-16 | |||||||||||
| 2015-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-03-17 | $0.00 derived: sum of 2 quarters · filed 2015-12-10 | $544.00K 10-Q · filed 2015-03-17 | $55.59M derived: sum of 4 quarters · filed 2017-03-16 | |||||||||||
| 2014-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-12-10 | $544.00K 10-Q · filed 2015-12-10 | $55.59M derived: sum of 3 quarters · filed 2017-03-16 | $62.02M derived: sum of 4 quarters · filed 2017-03-16 | |||||||||||
| 2014-07-31 | $544.00K 10-Q · filed 2015-09-09 | $55.59M derived: sum of 2 quarters · filed 2017-03-16 | $62.02M derived: sum of 3 quarters · filed 2017-03-16 | $62.59M derived: sum of 4 quarters · filed 2017-03-16 | |||||||||||
| 2014-04-30 | $55.04M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $61.48M derived: sum of 2 quarters · filed 2017-03-16 | $62.04M derived: sum of 3 quarters · filed 2017-03-16 | $62.04M 10-K · filed 2017-03-16 | |||||||||||
| 2014-01-31 | $6.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-03-17 | $7.00M derived: sum of 2 quarters · filed 2015-03-17 | $7.00M 10-Q · filed 2015-03-17 | $51.48M 10-Q · filed 2014-03-17 | |||||||||||
| 2013-10-31 | $567.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-12-15 | $567.00K 10-Q · filed 2014-12-15 | $45.05M 10-Q · filed 2013-12-17 | ||||||||||||
| 2013-07-31 | $0.00 10-Q · filed 2014-09-15 | $44.48M 10-Q · filed 2013-09-17 | |||||||||||||
| 2013-04-30 | $44.48M 10-K · filed 2013-06-26 | ||||||||||||||
| 2013-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-17 | $0.00 10-Q · filed 2014-03-17 | $44.48M 10-Q · filed 2013-03-18 | ||||||||||||
| 2012-10-31 | $0.00 10-Q · filed 2013-12-17 | $44.48M 10-Q · filed 2012-12-14 | |||||||||||||
| 2012-07-31 | $44.48M 10-Q · filed 2012-09-19 | ||||||||||||||
| 2012-04-30 | $114.45K derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-26 | $8.11M derived: sum of 2 quarters · filed 2013-06-26 | $8.73M derived: sum of 3 quarters · filed 2013-06-26 | $8.73M 10-K · filed 2013-06-26 | $44.48M 10-K · filed 2012-07-25 | ||||||||||
| 2012-01-31 | $8.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-03-18 | $8.62M derived: sum of 2 quarters · filed 2013-03-18 | $8.62M 10-Q · filed 2013-03-18 | $8.62M derived: sum of 4 quarters · filed 2013-03-18 | $44.36M 10-Q · filed 2012-03-15 | ||||||||||
| 2011-10-31 | $619.18K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-12-14 | $619.18K 10-Q · filed 2012-12-14 | $619.18K 10-Q · filed 2011-12-15 | $619.18K derived: sum of 3 quarters · filed 2012-12-14 | $619.18K derived: sum of 4 quarters · filed 2012-12-14 | $36.36M 10-Q · filed 2011-12-15 | |||||||||
| 2011-07-31 | $0.00 10-Q · filed 2011-09-19 | $0.00 derived: sum of 2 quarters · filed 2012-07-25 | $0.00 derived: sum of 3 quarters · filed 2012-07-25 | $0.00 derived: sum of 4 quarters · filed 2012-07-25 | $35.74M 10-Q · filed 2011-09-19 | ||||||||||
| 2011-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-07-25 | $0.00 derived: sum of 2 quarters · filed 2012-07-25 | $0.00 derived: sum of 3 quarters · filed 2012-07-25 | $4.90M 10-K · filed 2012-07-25 | |||||||||||
| 2011-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-03-15 | $0.00 derived: sum of 2 quarters · filed 2012-03-15 | $4.90M 10-Q · filed 2012-03-15 | ||||||||||||
| 2010-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2011-12-15 | $4.90M 10-Q · filed 2011-12-15 | |||||||||||||
| 2010-07-31 | $4.90M 10-Q · filed 2011-09-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |